免疫抑制治疗-话题@MedSci

#免疫抑制治疗#

25篇内容 | 1852人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1407199, encodeId=98f2140e199ef, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Eur Heart J：病毒阴性的炎症性心肌病患者免疫抑制治疗效果如何？, objectType=article, longId=732461, objectId=072be32461b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=072be32461b5, replyNumber=0, likeNumber=69, createdTime=2022-07-16, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=072be32461b5, moduleTitle=Eur Heart J：病毒阴性的炎症性心肌病患者免疫抑制治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=072be32461b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407198, encodeId=8801140e198f1, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Kidney Int Rep：他克莫司联合霉酚酸酯和糖皮质激素三联免疫抑制治疗狼疮性肾炎的远期疗效, objectType=article, longId=301722, objectId=2c4e301e225b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c4e301e225b, replyNumber=0, likeNumber=115, createdTime=2022-03-28, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c4e301e225b, moduleTitle=Kidney Int Rep：他克莫司联合霉酚酸酯和糖皮质激素三联免疫抑制治疗狼疮性肾炎的远期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c4e301e225b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407197, encodeId=281e140e19727, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=《2021年亚太肝病学会临床实践指南:与免疫抑制治疗相关的HBV再激活》摘译, objectType=article, longId=295205, objectId=5de729520580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5de729520580, replyNumber=0, likeNumber=66, createdTime=2022-02-08, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5de729520580, moduleTitle=《2021年亚太肝病学会临床实践指南:与免疫抑制治疗相关的HBV再激活》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5de729520580)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407196, encodeId=263f140e19659, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle= Clin Exp Immunol：获得性再生障碍性贫血中的干扰素 Gamma 和穿孔素阳性 T 细胞对免疫抑制治疗反应的预测, objectType=article, longId=294053, objectId=95a5294053bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95a5294053bb, replyNumber=0, likeNumber=82, createdTime=2022-01-17, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95a5294053bb, moduleTitle= Clin Exp Immunol：获得性再生障碍性贫血中的干扰素 Gamma 和穿孔素阳性 T 细胞对免疫抑制治疗反应的预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95a5294053bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407195, encodeId=d1a4140e19532, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=IBD : 早期联合免疫抑制治疗可以减少克罗恩病患者并发症的出现, objectType=article, longId=210396, objectId=e2d621039695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2d621039695, replyNumber=0, likeNumber=94, createdTime=2021-04-25, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2d621039695, moduleTitle=IBD : 早期联合免疫抑制治疗可以减少克罗恩病患者并发症的出现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2d621039695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407194, encodeId=3ba7140e1942e, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=BMJ：自体调节性T细胞输注治疗对肾移植后患者免疫抑制治疗的影响, objectType=article, longId=202488, objectId=9ce620248843, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce620248843, replyNumber=0, likeNumber=98, createdTime=2020-10-27, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce620248843, moduleTitle=BMJ：自体调节性T细胞输注治疗对肾移植后患者免疫抑制治疗的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce620248843)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407193, encodeId=2f93140e19320, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低, objectType=article, longId=202101, objectId=906420210148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=906420210148, replyNumber=0, likeNumber=79, createdTime=2020-10-16, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=906420210148, moduleTitle=Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=906420210148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407192, encodeId=48e8140e1921f, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=IBD: 早期联合免疫抑制治疗可以减少孤立的结肠型和回肠型克罗恩病并发症的发生, objectType=article, longId=197621, objectId=214c19e6213c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=214c19e6213c, replyNumber=0, likeNumber=82, createdTime=2020-07-18, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=214c19e6213c, moduleTitle=IBD: 早期联合免疫抑制治疗可以减少孤立的结肠型和回肠型克罗恩病并发症的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=214c19e6213c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407191, encodeId=12b6140e19173, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=J Cutan Med Surg：接受免疫抑制治疗的免疫介导性疾病患者的疫苗接种指南, objectType=article, longId=195888, objectId=3328195888fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3328195888fd, replyNumber=0, likeNumber=79, createdTime=2020-06-16, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3328195888fd, moduleTitle=J Cutan Med Surg：接受免疫抑制治疗的免疫介导性疾病患者的疫苗接种指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3328195888fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407190, encodeId=53fa140e190ad, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Ann Rheum Dis：接受手术类风湿性关节炎患者的免疫抑制治疗以及再入院和死亡风险, objectType=article, longId=190952, objectId=19401909524f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19401909524f, replyNumber=0, likeNumber=92, createdTime=2020-03-29, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19401909524f, moduleTitle=Ann Rheum Dis：接受手术类风湿性关节炎患者的免疫抑制治疗以及再入院和死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19401909524f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407189, encodeId=244f140e189f0, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=JCC：炎症性肠病相关感染与免疫抑制治疗及其对死亡率的影响, objectType=article, longId=176756, objectId=23701e675640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23701e675640, replyNumber=0, likeNumber=65, createdTime=2019-08-04, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23701e675640, moduleTitle=JCC：炎症性肠病相关感染与免疫抑制治疗及其对死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23701e675640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407188, encodeId=a6e3140e1882d, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=原发性膜性肾病，免疫抑制治疗是关键, objectType=article, longId=176419, objectId=d2af1e6419f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2af1e6419f7, replyNumber=0, likeNumber=76, createdTime=2019-07-31, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2af1e6419f7, moduleTitle=原发性膜性肾病，免疫抑制治疗是关键, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2af1e6419f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407187, encodeId=dccd140e18795, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=2019年DDW：联合免疫抑制治疗与老年克罗恩病患者并发症的风险上升无关, objectType=article, longId=166646, objectId=443e166646e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=443e166646e4, replyNumber=0, likeNumber=101, createdTime=2019-05-24, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=443e166646e4, moduleTitle=2019年DDW：联合免疫抑制治疗与老年克罗恩病患者并发症的风险上升无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=443e166646e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407186, encodeId=f5b6140e18665, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=AP&T：克罗恩病的老年患者早期联合免疫抑制治疗是安全有效的, objectType=article, longId=164329, objectId=807516432940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=807516432940, replyNumber=0, likeNumber=81, createdTime=2019-04-17, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=807516432940, moduleTitle=AP&T：克罗恩病的老年患者早期联合免疫抑制治疗是安全有效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=807516432940)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407185, encodeId=cfe8140e18571, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Lancet：贝利木单抗用于肾移植后的免疫抑制治疗, objectType=article, longId=140886, objectId=5d1f1408867c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1f1408867c, replyNumber=0, likeNumber=86, createdTime=2018-06-17, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1f1408867c, moduleTitle=Lancet：贝利木单抗用于肾移植后的免疫抑制治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1f1408867c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407184, encodeId=15e9140e184fd, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=2018 共识报告：免疫抑制治疗和乙型肝炎再激活风险, objectType=article, longId=138455, objectId=3f8213845565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8213845565, replyNumber=0, likeNumber=54, createdTime=2018-05-19, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8213845565, moduleTitle=2018 共识报告：免疫抑制治疗和乙型肝炎再激活风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f8213845565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407183, encodeId=7016140e18346, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Gastroenterology：炎症性肠病免疫抑制治疗与机会性感染风险, objectType=article, longId=135481, objectId=98a9135481bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98a9135481bb, replyNumber=0, likeNumber=73, createdTime=2018-04-18, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98a9135481bb, moduleTitle=Gastroenterology：炎症性肠病免疫抑制治疗与机会性感染风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98a9135481bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407182, encodeId=1037140e1825c, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=JACC:心脏移植后初始免疫抑制治疗：西罗莫司vs钙调神经磷酸酶抑制剂, objectType=article, longId=134609, objectId=58c1134609a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c1134609a6, replyNumber=0, likeNumber=75, createdTime=2018-04-10, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c1134609a6, moduleTitle=JACC:心脏移植后初始免疫抑制治疗：西罗莫司vs钙调神经磷酸酶抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c1134609a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407181, encodeId=dcea140e1814f, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=Clin Gastroenterol Hepatol：接受免疫抑制治疗的炎性肠病患者肺囊虫肺炎**风险高不高？, objectType=article, longId=102069, objectId=da8c102069c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da8c102069c8, replyNumber=0, likeNumber=85, createdTime=2017-06-17, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da8c102069c8, moduleTitle=Clin Gastroenterol Hepatol：接受免疫抑制治疗的炎性肠病患者肺囊虫肺炎**风险高不高？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da8c102069c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407180, encodeId=d139140e180e0, content=<a href='/topic/show?id=4128290361f' target=_blank style='color:#2F92EE;'>#免疫抑制治疗#</a>, objectTitle=JAMA：葡萄膜炎全身皮质类固醇和免疫抑制治疗与玻璃体腔植入临床长期结果, objectType=article, longId=98124, objectId=841398124b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=841398124b3, replyNumber=0, likeNumber=75, createdTime=2017-05-10, rootId=0, userName=liye789132252, userId=ffd62597391, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=841398124b3, moduleTitle=JAMA：葡萄膜炎全身皮质类固醇和免疫抑制治疗与玻璃体腔植入临床长期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=841398124b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫抑制治疗

2020-05-29

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Eur Heart J：病毒阴性的炎症性心肌病患者免疫抑制治疗效果如何？

2022-07-16

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Kidney Int Rep：他克莫司联合霉酚酸酯和糖皮质激素三联免疫抑制治疗狼疮性肾炎的远期疗效

2022-03-28

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

《2021年亚太肝病学会临床实践指南:与免疫抑制治疗相关的HBV再激活》摘译

2022-02-08

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Clin Exp Immunol：获得性再生障碍性贫血中的干扰素 Gamma 和穿孔素阳性 T 细胞对免疫抑制治疗反应的预测

2022-01-17

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

IBD : 早期联合免疫抑制治疗可以减少克罗恩病患者并发症的出现

2021-04-25

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

BMJ：自体调节性T细胞输注治疗对肾移植后患者免疫抑制治疗的影响

2020-10-27

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低

2020-10-16

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

IBD: 早期联合免疫抑制治疗可以减少孤立的结肠型和回肠型克罗恩病并发症的发生

2020-07-18

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

J Cutan Med Surg：接受免疫抑制治疗的免疫介导性疾病患者的疫苗接种指南

2020-06-16

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Ann Rheum Dis：接受手术类风湿性关节炎患者的免疫抑制治疗以及再入院和死亡风险

2020-03-29

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

JCC：炎症性肠病相关感染与免疫抑制治疗及其对死亡率的影响

2019-08-04

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

原发性膜性肾病，免疫抑制治疗是关键

2019-07-31

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

2019年DDW：联合免疫抑制治疗与老年克罗恩病患者并发症的风险上升无关

2019-05-24

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

AP&T：克罗恩病的老年患者早期联合免疫抑制治疗是安全有效的

2019-04-17

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Lancet：贝利木单抗用于肾移植后的免疫抑制治疗

2018-06-17

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

2018 共识报告：免疫抑制治疗和乙型肝炎再激活风险

2018-05-19

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Gastroenterology：炎症性肠病免疫抑制治疗与机会性感染风险

2018-04-18

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

JACC:心脏移植后初始免疫抑制治疗：西罗莫司vs钙调神经磷酸酶抑制剂

2018-04-10

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

Clin Gastroenterol Hepatol：接受免疫抑制治疗的炎性肠病患者肺囊虫肺炎**风险高不高？

2017-06-17

liye789132252 (审核中...)

前往app查看评论内容

#免疫抑制治疗#

JAMA：葡萄膜炎全身皮质类固醇和免疫抑制治疗与玻璃体腔植入临床长期结果

2017-05-10

科室
- - 订阅+
  - 更多科室
工具
服务